Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

Funds / Biopharma Secured Debt Fund II, Sarl

Biopharma Secured Debt Fund II, Sarl

Wound downCredit fundADV: Private Equity FundPharmakon Advisors, LPLuxembourgno longer reported
Amounts, each with its basis
Vintage
unknownno dated first sale, first report or announcement yet
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
unknownwhat may be sold, not what was raised
Form D sold
unknownno Form D on record
First sale
unknown
Reported gross assets
$138MForm ADV, as of Jun 13, 2017; not fund size, not dry powder
Peak reported gross assets
$363Mhighest year on the reporting tape
Owners (ADV)
51
Reported on ADV
Feb 15, 2012 to Jun 13, 2017
Structure
standalone
Fund of funds (ADV)
no
Strategy
Debt
Lifecycle
Wound down
rule: no longer reported on Form ADV while the adviser kept filingmodel: lc-pe-1gav path: 2012,363100000,2013,363100000,2014,290474743,2015,264078256,2016,203937969,2017,138491064as of year: $2,017reported years: 6first reported year: $2,012
Reported gross assets by year
6 annual rows
YearFiledTypeGross assets OwnersMin. investmentNon-US ownedSource
2012Feb 15, 2012Private Equity Fund$363M
53$026%adviserinfo.sec.gov
2013Apr 1, 2013Private Equity Fund$363M
53$026%adviserinfo.sec.gov
2014May 1, 2014Private Equity Fund$290M
53$026%adviserinfo.sec.gov
2015Apr 30, 2015Private Equity Fund$264M
53$026%adviserinfo.sec.gov
2016Jul 22, 2016Private Equity Fund$204M
51$032%adviserinfo.sec.gov
2017Jun 13, 2017Private Equity Fund$138M
51$032%adviserinfo.sec.gov
Placement agents and principals
2 placement agents, 0 principals
  • Groton Securities LLC placement agent since Jan 1, 2012 Fact
  • Vier Kleeblatt Investment Ag placement agent since Jan 1, 2012 Fact
Limited partners
0 disclosed
No LP commitment to this fund collected yet. An LP appears only when a public disclosure names this fund.
Investments attributed to this fund
0
No investment attributed to this fund. A firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Events
2 most recent
  1. Mar 29, 2018
    Fund 805-3130153519 no longer reported on Form ADV by Pharmakon Advisors, LP
    Fund no longer reported Inference SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
  2. Feb 15, 2012
    Biopharma Secured Debt Fund II, Sarl first reported on Form ADV by Pharmakon Advisors, LP (Private Equity Fund), GAV $363,100,000
    Fund first reported on Form ADV Inference SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)